# Pinpoint Therapeutics Inc. — Form D

Pinpoint Therapeutics Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-12. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-12-12
- Form: D
- Accession: 0001192482-19-000514
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Minimum investment: $1.0M
- Investors: 1
- Date of first sale: 2019-11-26
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-355367

## Issuer

- Name: Pinpoint Therapeutics Inc.
- CIK: 0001796645
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 3401 GRAYS FERRY AVENUE, PHILADELPHIA, PA, 19146
- Phone: 610-308-9229

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Christian Peters | Director | Philadelphia, PA |
| Christian Peters | Executive Officer | Philadelphia, PA |

## More

- [CIK 1796645 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1796645&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001192482-19-000514.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.